Works by BARAT, SHOMA
Results: 7
Overall survival and morbidity are not associated with advanced age for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience.
- Published in:
- Pleura & Peritoneum, 2023, v. 8, n. 2, p. 83, doi. 10.1515/pp-2022-0202
- By:
- Publication type:
- Article
Survival benefits with EPIC in addition to HIPEC for low grade appendiceal neoplasms with pseudomyxoma peritonei: a propensity score matched study.
- Published in:
- Pleura & Peritoneum, 2023, v. 8, n. 1, p. 27, doi. 10.1515/pp-2022-0205
- By:
- Publication type:
- Article
Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation.
- Published in:
- Pleura & Peritoneum, 2021, v. 6, n. 4, p. 155, doi. 10.1515/pp-2021-0130
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy does not improve survival for patients with high volume colorectal peritoneal metastases undergoing cytoreductive surgery.
- Published in:
- World Journal of Surgical Oncology, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12957-024-03392-8
- By:
- Publication type:
- Article
Mutations of the CEACAM5 Gene PELPK Motif in Patients With Appendiceal or Colorectal Adenocarcinoma.
- Published in:
- In Vivo, 2025, v. 39, n. 1, p. 96, doi. 10.21873/invivo.13806
- By:
- Publication type:
- Article
Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC).
- Published in:
- In Vivo, 2022, v. 36, n. 5, p. 2350, doi. 10.21873/invivo.12966
- By:
- Publication type:
- Article
Cost-effectiveness of Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis.
- Published in:
- In Vivo, 2022, v. 36, n. 3, p. 1527, doi. 10.21873/invivo.12863
- By:
- Publication type:
- Article